Cargando…
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
BACKGROUND: The radical cure of Plasmodium vivax requires treatment with an 8-aminoquinoline drug, such as primaquine and tafenoquine, to eradicate liver hypnozoite stages, which can reactivate to cause relapsing infections. Safe treatment regimens require prior screening of patients for glucose-6-p...
Autores principales: | Engel, Nora, Ghergu, Cristian, Matin, Mohammad Abdul, Kibria, Mohammad Golam, Thriemer, Kamala, Price, Ric N., Ding, Xavier C., Howes, Rosalind E., Ley, Benedikt, Incardona, Sandra, Alam, Mohammad Shafiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114691/ https://www.ncbi.nlm.nih.gov/pubmed/33980257 http://dx.doi.org/10.1186/s12936-021-03743-w |
Ejemplares similares
-
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study
por: Ley, Benedikt, et al.
Publicado: (2016) -
A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2017) -
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2020) -
Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case–control data from Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2021) -
Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
por: Alam, Mohammad Shafiul, et al.
Publicado: (2018)